Schedule (route) |
Endpoint |
Vehicle |
Dose |
Treated/Control (%) |
Observations |
Q04DX003 (ip) |
mean tumor weight change |
saline |
2.5 mg/kg/injection |
64.0 |
Antitumor endpoint evaluated on day 10; 05/06 animals surviving on day 10 |
Q04DX003 (ip) |
mean tumor weight change |
saline |
2.5 mg/kg/injection |
77.0 |
Antitumor endpoint evaluated on day 12; 06/06 animals surviving on day 12 |
Q04DX003 (ip) |
mean tumor weight change |
saline |
5.0 mg/kg/injection |
40.0 |
Antitumor endpoint evaluated on day 10; 06/06 animals surviving on day 10 |
Q04DX003 (ip) |
mean tumor weight change |
saline |
5.0 mg/kg/injection |
36.0 |
Antitumor endpoint evaluated on day 12; 04/05 animals surviving on day 12 |
Q04DX003 (ip) |
mean tumor weight change |
saline |
10.0 mg/kg/injection |
-48.0 |
Antitumor endpoint evaluated on day 10; 06/06 animals surviving on day 10 |
Q04DX003 (ip) |
mean tumor weight change |
saline |
10.0 mg/kg/injection |
3.0 |
Antitumor endpoint evaluated on day 12; 06/06 animals surviving on day 12 |
Q04DX003 (ip) |
mean tumor weight change |
saline |
20.0 mg/kg/injection |
0.0 |
Antitumor endpoint evaluated on day 10; 00/06 animals surviving on day 10 |
Q04DX003 (ip) |
mean tumor weight change |
saline |
20.0 mg/kg/injection |
0.0 |
Antitumor endpoint evaluated on day 12; 02/06 animals surviving on day 12 |